Next Science Ltd (AU:NXS) recently announced a significant update regarding its sales force structure. The company has implemented changes to reduce costs and enhance operational efficiency, with anticipated annual savings of approximately US$6 million. These changes come as Next Science reports a rise in product sales and a strong gross margin, indicating a positive outlook for the future.
The company is confident in its ability to meet its FY24 revenue guidance of US$36m-$40m, while also aiming to achieve EBITDA and positive cashflow in the second half of the fiscal year. This strategic shift includes moving towards a more flexible, commission-based sales team and leveraging new market opportunities to drive further growth.
Investors interested in AU:NXS stock can find more information on TipRanks’ Stock Analysis page.